Compare ESOA & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESOA | ARMP |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Water Sewer Pipeline Comm & Power Line Construction | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 288.3M | 295.5M |
| IPO Year | 2006 | 1996 |
| Metric | ESOA | ARMP |
|---|---|---|
| Price | $16.70 | $7.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $21.00 | $15.00 |
| AVG Volume (30 Days) | ★ 132.0K | 60.6K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $122,465,826.00 | N/A |
| Revenue This Year | $9.22 | N/A |
| Revenue Next Year | $3.77 | N/A |
| P/E Ratio | $96.47 | ★ N/A |
| Revenue Growth | ★ 2.74 | N/A |
| 52 Week Low | $7.84 | $1.74 |
| 52 Week High | $19.94 | $14.98 |
| Indicator | ESOA | ARMP |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 41.93 |
| Support Level | $16.62 | $7.22 |
| Resistance Level | $19.94 | $7.70 |
| Average True Range (ATR) | 0.88 | 0.68 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 54.55 | 43.10 |
Energy Services of America Corporation is engaged in providing contracting services for energy-related companies. The company is predominantly engaged in the construction, replacement, and repair of natural gas pipelines and storage facilities for utility companies and private natural gas companies. It services the gas, petroleum, power, chemical, and automotive industries and does incidental work such as water and sewer projects. Energy Service's other services include liquid pipeline construction, pump station construction, production facility construction, water and sewer pipeline installations, various maintenance and repair services, and other services related to pipeline construction.
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.